Capsule containing oldenlandia and Urena lobata

A technology of composition and capsule, which is applied in the field of capsules containing bonus composition, can solve problems such as the influence of treatment effect, and achieve the effect of improving treatment effect

Inactive Publication Date: 2007-05-16
GUANGXI HUAHONG PHARMACEUTICAL CO LTD
View PDF2 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Its defects are very significant. The drying temperature is above 90°C, and the weight content of quercetin in the composition is generally only below 0.0006%, which greatly affects the therapeutic effect.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Capsule containing oldenlandia and Urena lobata

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0037] raw material:

[0038] A little red 1667g Hedyotis diffusa 1000g Peach blossom 1667g

[0039] 1000 grams of white back tung tree

[0040] Myrtle Root 1667g.

[0041] The above Qiwei herbs are decocted twice with 15 times the weight of water, the first time is 2 hours, and the second time is 1.5 hours. Paste, add ethanol to make the alcohol content reach 65%, stir well, let it stand for 24 hours, filter, recover ethanol from the filtrate under reduced pressure and concentrate to a clear paste with a relative density of 1.25-1.30 (80°C), and vacuum-dry at 60°C , crushed into 100-300 mesh fine powder, that is.

[0042] Detection of the content of quercetin:

[0043] Measure according to high performance liquid chromatography (Appendix VI D of Chinese Pharmacopoeia edition in 2000)

[0044] Chromatographic conditions and system suitability test:

[0045] Octadecylsilane bonded silica gel is used as filler; methanol-0.9% phosphoric acid solution (1:1) is used as mobile...

Embodiment 2

[0053] prescription:

[0054] A little red 1500g Hedyotis diffusa 1500g Peach blossom 2000g

[0055] White back tung tree 500g, scorpion 500g, Caulis Spatholobus 1800g

[0056] Myrtle Root 2000g.

[0057] Using the same method as in Example 1, the drying temperature was 80°C. Based on the total weight of the composition, containing Hedyotis diffusa and quercetin (C 15 h 10 o 7 ) is calculated as 0.010%, percentage by weight.

[0058] The detection method is the same as in Example 1.

Embodiment 3

[0064] prescription:

[0065] Composition 184 grams of embodiment 1

[0066] Accessories: 33 grams of cornstarch

[0067] 25g microcrystalline cellulose

[0068] Magnesium stearate 8 g

[0069] The method known in the art is used to prepare capsules, each capsule weighs 0.25 g, and the weight content of quercetin is 0.07%.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention discloses a capsule preparation containing Malus asiatica Nakai composition and its preparing process, wherein the capsules comprise capsule shells and content therein, the content comprises treatment effective amount of Malus asiatica Nakai composition and pharmaceutically acceptable carriers. In the Malus asiatica Nakai composition, the weight content of quercetin is 0.06-0.11% by weight of total amount of Malus asiatica Nakai composition calculated by C15H1007.

Description

technical field [0001] The invention relates to a bonus composition for treating women's diseases, in particular to a capsule containing the bonus composition. Background technique [0002] Pelvic inflammatory disease is a common disease in women, including inflammation of pelvic reproductive organs, such as uterine body, fallopian tubes, ovaries, etc., as well as pelvic peritoneum and connective tissue around the uterus. High incidence age of pelvic inflammatory disease. Seriously affected people's life and work. For this reason, many scientific and technical workers and relevant pharmaceutical manufacturers have disclosed their own medicines for the treatment of pelvic inflammatory disease, including traditional Chinese medicine preparations and chemically synthesized medicines. Obtained people's favor, such as the technology reported in Chinese Patent Publication No. CN1586519A and CN1552371A, commercialized production such as "Gynecology Qianjin Tablet" produced by Chi...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): A61K36/76A61K9/48A61P15/00
Inventor 韦飞燕
Owner GUANGXI HUAHONG PHARMACEUTICAL CO LTD
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap